International Journal of

ADVANCED AND APPLIED SCIENCES

EISSN: 2313-3724, Print ISSN: 2313-626X

Frequency: 12

line decor
  
line decor

 Volume 7, Issue 2 (February 2020), Pages: 9-14

----------------------------------------------

 Original Research Paper

 Title: A case-control study on various risk factors causing coronary artery disease among patients of the selected hospital in Hail region, Kingdom of Saudi Arabia

 Author(s): Salman Alsaqri 1, *, Silvia Edison 1, Neama Ahmed Hamed 1, Nouf Mehajaa Al Enzi 1, Hanan Haj Ahmad 2

 Affiliation(s):

 1Medical Surgical Department, College of Nursing, University of Hail, Hail, Saudi Arabia
 2Mathematical Department, College of Science, University of Hail, Hail, Saudi Arabia

  Full Text - PDF          XML

 * Corresponding Author. 

  Corresponding author's ORCID profile: https://orcid.org/0000-0002-9178-2946

 Digital Object Identifier: 

 https://doi.org/10.21833/ijaas.2020.02.002

 Abstract:

Certain risk factors increase the probability of developing coronary artery disease and it increases the number of death all over the World. The aim of this study is to identify the various risk factors in cases among subjects with coronary artery disease and in the control population who are unaffected with coronary artery disease and aimed to estimate the odds ratio among cases and controls. A case-control Epidemiological observational study was used. Sample Case: Patients with coronary artery disease were included. Control: Matched outpatients who don’t have coronary artery disease and fulfill the inclusion criteria. The sample size of this study in each group was 40. For Cases Simple random sampling technique was used and Controls are chosen randomly who were matching with the case group. Smoking acts as the strongest risk factor with p-value zero, so the odds of having CAD is 31 times in smokers than non-smokers. This is followed by anti-hypertensive Drug which has an odd of CAD with 10.5 times on patients taking anti-hypertensive drugs than those who do not take such drugs. The studied population has a high prevalence and clustering of traditional risk factors. 

 © 2020 The Authors. Published by IASE.

 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

 Keywords: Risk factors, Coronary artery disease, Case, Control

 Article History: Received 1 September 2019, Received in revised form 27 November 2019, Accepted 2 December 2019

 Acknowledgment:

The research investigators would like to express their gratitude toward the University of Hail for funding this project and we are indebted to all the patients of King Khalid hospital in Hail, Kingdom of Saudi Arabia, who freely gave their time to participate in this study.

 Compliance with ethical standards

 Ethical considerations All potential participants were informed of the purpose of the study and were given the choice not to participate. Written informed consent was secured prior to data collection. Confidentiality was a priority in this study, so no personal identifications were requested.

 Conflict of interest:  The authors declare that they have no conflict of interest.

 Citation:

 Alsaqri S, Edison S, and Hamed NA et al. (2020). A case-control study on various risk factors causing coronary artery disease among patients of the selected hospital in Hail region, Kingdom of Saudi Arabia. International Journal of Advanced and Applied Sciences, 7(2): 9-14

 Permanent Link to this page

 Figures

 No Figure

 Tables

 Table 1 Table 2 Table 3

----------------------------------------------

 References (19) 

  1. Al-Nozha MM, Arafah MR, Al-Mazrou YY, Al-Maatouq MA, Khan NB, Khalil MZ, and Al-Shahid MS (2004). Coronary artery disease in Saudi Arabia. Saudi Medical Journal, 25(9): 1165-1171.   [Google Scholar]
  2. Anderson KM, Castelli WP, and Levy D (1987). Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA, 257(16): 2176-2180. https://doi.org/10.1001/jama.257.16.2176   [Google Scholar] PMid:3560398
  3. Carnethon MR (2009). Physical activity and cardiovascular disease: How much is enough? American Journal of Lifestyle Medicine, 3(1_suppl): 44S-49S. https://doi.org/10.1177/1559827609332737   [Google Scholar] PMid:20419076 PMCid:PMC2857374
  4. Doyle JT, Dawber TR, Kannel WB, Heslin AS, and Kahn HA (1962). Cigarette smoking and coronary heart disease: Combined experience of the Albany and Framingham studies. New England Journal of Medicine, 266(16): 796-801. https://doi.org/10.1056/NEJM196204192661602   [Google Scholar] PMid:13887664
  5. Filippidis FT, Laverty AA, Gerovasili V, and Vardavas CI (2017). Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tobacco Control, 26(1): 98-104. https://doi.org/10.1136/tobaccocontrol-2015-052771   [Google Scholar] PMid:27220621 PMCid:PMC5256312
  6. Hackshaw A, Morris JK, Boniface S, Tang JL, and Milenković D (2018). Low cigarette consumption and risk of coronary heart disease and stroke: Meta-analysis of 141 cohort studies in 55 study reports. BMJ, 360: j5855. https://doi.org/10.1136/bmj.j5855   [Google Scholar] PMid:29367388 PMCid:PMC5781309
  7. Hajar R (2017). Risk factors for coronary artery disease: Historical perspectives. Heart Views: The Official Journal of the Gulf Heart Association, 18(3): 109-114. https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17   [Google Scholar] PMid:29184622 PMCid:PMC5686931
  8. Inoue T (2004). Cigarette smoking as a risk factor of coronary artery disease and its effects on platelet function. Tobacco Induced Diseases, 2: 27. https://doi.org/10.1186/1617-9625-2-1-27   [Google Scholar] PMid:19570268 PMCid:PMC2671517
  9. James C, Tisheva SAT, Jose S, and Nair B (2015). A study of risk factors for coronary artery disease among patients with ischemic heart disease in the state of Kerala in south India. Journal of Hypertension, 33(e-Supplement 1): e273. https://doi.org/10.1097/01.hjh.0000468196.88325.e4   [Google Scholar]
  10. Khan RJ, Harvey DJ, Leistikow BN, Haque KS, and Stewart CP (2015). Relationship between obesity and coronary heart disease among urban Bangladeshi men and women. Integrative Obesity and Diabetes, 1(3): 49-55. https://doi.org/10.15761/IOD.1000112   [Google Scholar]
  11. Krishnan MN, Zachariah G, Venugopal K, Mohanan PP, Harikrishnan S, Sanjay G, and Thankappan KR (2016). Prevalence of coronary artery disease and its risk factors in Kerala, South India: A community-based cross-sectional study. BMC Cardiovascular Disorders, 16: 12. https://doi.org/10.1186/s12872-016-0189-3   [Google Scholar] PMid:26769341 PMCid:PMC4712491
  12. Lakier JB (1992). Smoking and cardiovascular disease. The American Journal of Medicine, 93(1): S8-S12. https://doi.org/10.1016/0002-9343(92)90620-Q   [Google Scholar]
  13. O'Donnell CJ and Elosua R (2008). Cardiovascular risk factors: Insights from Framingham heart study. Revista Espanola de Cardiologia (English Edition), 61(3): 299-310. https://doi.org/10.1016/S1885-5857(08)60118-8   [Google Scholar]
  14. Rosenberg L, Kaufman DW, Helmrich SP, and Shapiro S (1985). The risk of myocardial infarction after quitting smoking in men under 55 years of age. New England Journal of Medicine, 313(24): 1511-1514. https://doi.org/10.1056/NEJM198512123132404   [Google Scholar] PMid:4069159
  15. Stallones RA (2015). The association between tobacco smoking and coronary heart disease. International Journal of Epidemiology, 44(3): 735-743. https://doi.org/10.1093/ije/dyv124   [Google Scholar] PMid:26174518
  16. Stamler J, Wentworth D, and Neaton JD (1986). Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the multiple risk factor intervention trial (MRFIT). The Journal of the American Medical Association, 256(20): 2823-2828. https://doi.org/10.1001/jama.256.20.2823   [Google Scholar] PMid:3773199
  17. Wang CCL, Hess CN, Hiatt WR, and Goldfine AB (2016). Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes–mechanisms, management, and clinical considerations. Circulation, 133(24): 2459-2502. https://doi.org/10.1161/CIRCULATIONAHA.116.022194   [Google Scholar] PMid:27297342 PMCid:PMC4910510
  18. WHO (2018). World Health Organization (WHO) plan to eliminate industrially-produced trans-fatty acids from global food supply. World Health Organization, Geneva, Switzerland.
  19. Winzer EB, Woitek F, and Linke A (2018). Physical activity in the prevention and treatment of coronary artery disease. Journal of the American Heart Association, 7(4): e007725. https://doi.org/10.1161/JAHA.117.007725   [Google Scholar] PMid:29437600 PMCid:PMC5850195